- Home
- INZY vs BZUN Comparison
INZY vs BZUN Comparison
Compare INZY & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- BZUN
- Stock Information
- Founded
- INZY 2015
- BZUN 2007
- Country
- INZY United States
- BZUN China
- Employees
- INZY N/A
- BZUN N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- BZUN Catalog/Specialty Distribution
- Sector
- INZY Health Care
- BZUN Consumer Discretionary
- Exchange
- INZY Nasdaq
- BZUN Nasdaq
- Market Cap
- INZY 188.2M
- BZUN 188.7M
- IPO Year
- INZY 2020
- BZUN N/A
- Fundamental
- Price
- INZY $1.36
- BZUN $3.25
- Analyst Decision
- INZY Strong Buy
- BZUN Strong Buy
- Analyst Count
- INZY 8
- BZUN 3
- Target Price
- INZY $17.75
- BZUN $3.20
- AVG Volume (30 Days)
- INZY 1.0M
- BZUN 427.0K
- Earning Date
- INZY 03-11-2025
- BZUN 03-20-2025
- Dividend Yield
- INZY N/A
- BZUN N/A
- EPS Growth
- INZY N/A
- BZUN N/A
- EPS
- INZY N/A
- BZUN N/A
- Revenue
- INZY N/A
- BZUN $1,312,737,613.00
- Revenue This Year
- INZY N/A
- BZUN $8.16
- Revenue Next Year
- INZY N/A
- BZUN $4.71
- P/E Ratio
- INZY N/A
- BZUN N/A
- Revenue Growth
- INZY N/A
- BZUN 7.26
- 52 Week Low
- INZY $1.24
- BZUN $2.11
- 52 Week High
- INZY $7.80
- BZUN $4.38
- Technical
- Relative Strength Index (RSI)
- INZY 29.28
- BZUN 58.19
- Support Level
- INZY $1.35
- BZUN $3.05
- Resistance Level
- INZY $1.62
- BZUN $3.43
- Average True Range (ATR)
- INZY 0.13
- BZUN 0.17
- MACD
- INZY 0.04
- BZUN 0.03
- Stochastic Oscillator
- INZY 32.89
- BZUN 74.26
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).